Navigation Links
HMS Holdings Corp. to Present at Investor Conferences
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (Nasdaq: HMSY) today announced that it will present at the following investor conferences.

    Conference:    Morgan Stanley Global Healthcare Conference
    Date/Time:     Tuesday, September 15, 2009 at 2:45 p.m. ET
    Location:      New York
    Presenter:     Bill Lucia, President and Chief Executive Officer

    Conference:    ThinkEquity Partners' 6th Annual Growth Conference: G6
    Date/Time:     Thursday, September 17, 2009 at 9:00 a.m. PT
    Location:      San Francisco
    Presenter:     Walter Hosp, SVP and Chief Financial Officer

HMS Holdings Corp. (HMS) is the leader in coordination of benefits and program integrity services for government healthcare programs. The company's clients include health and human services programs in more than 40 states, 100 Medicaid managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1 billion annually, and avoid billions of dollars more in erroneous payments.


'/>"/>
SOURCE HMS Holdings Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmer Holdings to Present at Upcoming Investor Conferences
2. China Pharma Holdings, Inc. Announces Participation in September Conferences
3. LifeCare Holdings, Inc. Announces Second Quarter Results
4. China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results and Corporate Updates
5. Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures
6. Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015
7. Innophos Holdings, Inc. Reports Second Quarter 2009 Results
8. JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc.
9. Duane Reade Holdings, Inc. Announces Pricing of Offering of 11.75% Senior Secured Notes Due 2015
10. HMS Holdings Corp. Announces Q2 2009 Results and Raises 2009 Guidance
11. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... specializing in medical device compliance and commercialization, has just released a new ... , FDA is more adamant than ever about medical device, pharmaceutical, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of The Garland ... a redesigned website. The new site – still located at http://www.garlandco.com ... and other industry users that Garland serves. , After an ambitious phase of ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Health & Safety Institute (HSI) is offering discounted pricing ... 40-Hour courses from now until November 30, 2017 to assist with the clean-up efforts ... to all businesses and government agencies – whether or not they will be directly ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of ... life. This mouse sets out on a journey that will show that friends are ... creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: